NUTRA PHARMA CORP. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NUTRA PHARMA CORP. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2017-12-31 was 2.00M shares.
- NUTRA PHARMA CORP. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2017-09-30 was 0.00 shares.
- NUTRA PHARMA CORP. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2013-09-30 was 0.00 shares.
- NUTRA PHARMA CORP. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2013-06-30 was 0.00 shares.
- NUTRA PHARMA CORP. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2017 was 1.00M shares.
- NUTRA PHARMA CORP. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2015 was -1.00M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2017-12-31 | 2.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-05 | 1.00M shares 10-K · filed 2021-02-05 |
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-20 | |
| 2015-12-31 | -1.00M shares 10-K · filed 2017-04-17 | |
| 2013-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-19 | |
| 2013-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-19 | |
| 2013-03-31 | 0.00 shares 10-Q · filed 2013-05-20 |